Literature DB >> 15329910

Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Jian-Min Yuan1, Sugantha Govindarajan, Kazuko Arakawa, Mimi C Yu.   

Abstract

BACKGROUND: Heavy alcohol consumption, viral hepatitis, and diabetes are risk factors for hepatocellular carcinoma (HCC). However, to the authors' knowledge, the information concerning their interaction effect in patients with risk of HCC is sparse.
METHODS: A population-based, case-control study of HCC was conducted during 1984-2002. The study involved 295 HCC cases and 435 age-, gender-, and race-matched control subjects among Hispanic and non-Hispanic whites and blacks in Los Angeles County, California. Lifestyle risk factors were ascertained through in-person interviews. Infections with the hepatitis B and C (HCV) viruses were determined using their serologic markers.
RESULTS: Fourteen HCC cases but no control subjects tested positive for the hepatitis B surface antigen. Seropositivity for antibodies to HCV was associated with an odds ratio (OR) of 125 (95% confidence interval [95% CI], 17-909) for HCC, whereas seropositivity for antibodies to the hepatitis B core antigen was related to an OR of 2.9 (95% CI, 1.7-5.0). Heavy alcohol consumption and cigarette smoking were found to be independently associated with a statistically significant two to threefold increase in risk of HCC after adjustment for hepatitis B and C serology. Subjects with a history of diabetes had an OR of 2.7 (95% CI, 1.6-4.3) for HCC compared with nondiabetic subjects. A synergistic interaction on HCC risk was observed between heavy alcohol consumption and diabetes (OR = 4.2; 95% CI, 2.6-5.8), heavy alcohol consumption and viral hepatitis (OR = 5.5; 95% CI, 3.9-7.0), or between diabetes and viral hepatitis (OR = 4.8; 95% CI, 2.7-6.9).
CONCLUSIONS: Heavy alcohol consumption, diabetes, and viral hepatitis were found to exert independent and synergistic effects on risk of HCC in U.S. blacks and whites. Copyright 2004 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329910     DOI: 10.1002/cncr.20427

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  114 in total

Review 1.  Alcohol use of diabetes patients: the need for assessment and intervention.

Authors:  Patricia A Engler; Susan E Ramsey; Robert J Smith
Journal:  Acta Diabetol       Date:  2010-06-08       Impact factor: 4.280

2.  Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis.

Authors:  Shu-Chun Chuang; Yuan-Chin Amy Lee; Mia Hashibe; Min Dai; Tongzhang Zheng; Paolo Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

3.  Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population.

Authors:  Seung Ha Park; Nae Yun Heo; Jong Ha Park; Tae Oh Kim; Sung Yeun Yang; Hyun Kuk Kim; Young Soo Moon; Chang Hoon Kim; Ki Tae Suk; Dong Joon Kim; Heon Young Lee
Journal:  Dig Dis Sci       Date:  2012-06-23       Impact factor: 3.199

4.  NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.

Authors:  Chia-Lin Chen; Dinesh Babu Uthaya Kumar; Vasu Punj; Jun Xu; Linda Sher; Stanley M Tahara; Sonja Hess; Keigo Machida
Journal:  Cell Metab       Date:  2015-12-24       Impact factor: 27.287

5.  Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.

Authors:  Xian-Feng Shen; Xian-Tao Zeng; Zhi-Yuan Jian; Meng Zhou; Ping Zhou; Min Zhang
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

6.  Hematopoietic-substrate-1 associated protein X-1 (HAX-1) regulates liver cancer cells growth, metastasis, and angiogenesis through Akt.

Authors:  Zhenyu Wu; Xiangnan Ai; Hao Hu; Siqi Wang; Yang Wang; Feng Kang; Caiguo Ouyang; Jiye Zhu
Journal:  Cancer Biol Ther       Date:  2019-05-27       Impact factor: 4.742

7.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

8.  Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999-2009.

Authors:  Stephanie C Melkonian; Melissa A Jim; Brigg Reilley; Jennifer Erdrich; Zahava Berkowitz; Charles L Wiggins; Donald Haverkamp; Mary C White
Journal:  Cancer Causes Control       Date:  2018-07-20       Impact factor: 2.506

9.  Alcohol-associated cancer and deregulation of Pol III genes.

Authors:  Ganggang Shi; Shuping Zhong
Journal:  Gene       Date:  2016-09-30       Impact factor: 3.688

10.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.